| Child |
0 |
1 |
| COVID-19 |
0 |
0.93 |
| Obesity |
0 |
0.49 |
| Systemic Lupus Erythematosus |
0 |
0.19 |
| Disease-Modifying Antirheumatic Drugs |
0 |
0.17 |
| Arthritis |
0 |
0.13 |
| Glucocorticoid |
0 |
0.13 |
| Pandemic |
0 |
0.13 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.13 |
| Uveitis |
0 |
0.13 |
| Vasculitis |
0 |
0.11 |
| Body Mass Index |
0 |
0.09 |
| Intraocular Inflammation |
0 |
0.09 |
| Lupus |
0 |
0.09 |
| Severe Acute Respiratory Syndrome |
0 |
0.09 |
| Juvenile Rheumatoid Arthritis (JRA) |
0 |
0.08 |
| Acute Respiratory Distress Syndrome |
0 |
0.07 |
| Biologic Therapy |
0 |
0.07 |
| Hypertension |
0 |
0.07 |
| Mixed Connective Tissue Disease |
0 |
0.07 |
| Connective Tissue Disease |
0 |
0.06 |
| Interstitial Lung Disease |
0 |
0.06 |
| Asthma |
0 |
0.05 |
| Data Collection |
0 |
0.04 |
| Europe |
0 |
0.04 |
| Heart |
0 |
0.04 |
| Immunization |
0 |
0.04 |
| Immunocompromise |
0 |
0.04 |
| Immunosuppressive Therapy |
0 |
0.04 |
| Lung |
0 |
0.04 |
| Myopathy |
0 |
0.04 |
| NHS |
0 |
0.04 |
| Osteomyelitis |
0 |
0.04 |
| Polymerase Chain Reaction |
0 |
0.04 |
| Remission |
0 |
0.04 |
| Renal Disease |
0 |
0.04 |
| Tissue |
0 |
0.04 |
| Tumor |
0 |
0.04 |
| Cerebrovascular Accident |
0 |
0.03 |
| Inflammatory Bowel Disease |
0 |
0.03 |
| Psoriasis |
0 |
0.03 |
| Sarcoidosis |
0 |
0.03 |
| Vaccines |
0 |
0.03 |